series-a
Stage
1
Investors
About
Rodin Therapeutics develops therapeutics aimed at restoring cognitive function by targeting the biological mechanisms underlying memory loss and neurodegenerative diseases.
Explore Rodin Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.